Despite recommended prophylaxis, symptomatic VTE occurs in approximately 1% of knee and 0.5% of hip arthroplasty patients before hospital discharge.
Using current VTE prophylaxis, approximately 1 in 100 patients undergoing TPKA and approximately 1 in 200 patients undergoing TPHA develops symptomatic VTE prior to hospital discharge.
Januel et al. (Tue,) studied this question.